Tirzepatide: GLP-1/GIP for Glucose & Weight

$45.00

Tirzepatide is an innovative medication that treats both type 2 diabetes and promotes weight loss. This treatment works as a dual agonist. It targets the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors in the body. By stimulating these receptors, tirzepatide enhances insulin secretion when blood sugar levels rise. This helps lower glucose levels after meals.

466 Items sold in last 3 days
16 People watching this product now!
SKU: N/A Category:
Description

Benefits of Tirzepatide

Tirzepatide activates both GIP and GLP-1 receptors, improving blood sugar control and weight management through multiple pathways:

✅Promoting insulin secretion (glucose dependence, reducing the risk of hypoglycemia)
✅Inhibiting glucagon secretion (reducing liver glucose output)
✅Delaying gastric emptying (increasing satiety and reducing food intake)
✅Regulating central appetite (reducing hunger)

Clinical effects

1. Glycemic-lowering effect: In patients with type 2 diabetes, HbA1c (glycosylated hemoglobin) can be reduced by 1.8%~2.4% (SURPASS trial).
2. Weight loss effect: In obese or overweight patients (without diabetes), the average weight loss was 15%~22.5% (SURMOUNT trial).

Additional information
Reviews (0)
Shipping & Delivery